DSM and Sanquin sign manufacturing agreement for factor IX antibody

10/24/2013 | Genetic Engineering & Biotechnology News

Sanquin Blood Supply Foundation and DSM Pharmaceutical Products have signed a commercial manufacturing agreement to produce a monoclonal antibody for the recovery and purification of coagulation factor IX from human blood. Production will take place at a DSM Biologics facility in the Netherlands.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA